COPD

What is the large-scale study looking to bring to clinical respiratory health understanding?

In what ways do the respiratory conditions differentiate in progression and care options?

A 600-city analysis of particulate matter found daily exposure is linked to worsened mortality rates, particularly in areas with higher mean temperatures.

A new study found significantly greater COPD development risk among middle-aged women who eat processed meat—and doubly worse risk for those who also smoke and have unhealthy diets.

Analysis from the CARDIA Lung study found patients with worsened FEV1 are at greater risk for emphysema, regardless of their smoker status.

Study of more than 650 COPD patients found that CRP-guided prescribing resulted in a lower percentage of patients who reported antibiotic use.

A recent study of more than 300,000 found that exposure to outdoor air pollution is linked to decreased lung function and an increased risk of COPD.

Regardless of which care provider is diagnosing and treating the patient, all must be aware of the treatment access burdens.

After showing the ability to regain patients' senses of smell and taste in a pair of phase 3 trials, the biologic becomes the first indicated for CRSwNP.

A new pooled cohort analysis supports the longheld threshold of < .70 FEV1:FVC ratio to indicate patient risks from COPD-related events.

A three-arm clinical trial of the SAMBA program showed that screening for and tailoring to individuals' asthma needs improves their condition management.

New findings better evidence the link between long-term COPD exacerbations and poor patient sleep quality. How well-understood is the association between sleep and pulmonary conditions?

Overall rates of pulmonary rehabilitation rose in areas with greater program density, but rates for African Americans remained low despite greater program density.

Mental health disorders are highly prevalent in certain patients with COPD&mdash;and their effect can limit lung function therapy benefit.

Does it matter whether federal and state regulations allow for a significant user population?

High-risk LIVE scores for patients with COPD were associated with higher all-cause mortality and higher rates of referral to palliative care.

New Sunovion data at ATS 2019 shows expected trends of comorbidity effect on patients, and surprising results of care between men and women.

New clinical findings go against the advisory of the GOLD 2017 classification.

Most surveyed comorbid patients reported they required the help of family, friends or caregivers during pneumonia recovery, and needed an average of 28 days of care.

Despite decreasing tobacco use in the US, the prevalence of COPD has not dropped.

Economic factors can influence ER department patient disposition, despite prohibitions against such practice.

Certified respiratory educators helped a COPD intervention group of patients achieve improved symptom results.

A comparison of hospitalized COPD patients treated with either short-acting or long-acting bronchodilator showed the latter had no influence on 30-day readmission rates.

Duaklier Pressair is a is a fixed-dose combination of the long-acting muscarinic antagonist aclidinium and the long-acting beta agonist formoterol.

The LAMA/LABA combination therapy was shown to reduce one-year exacerbation rates while not increasing patient risk of cardiovascular events.